Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 14 studies | 29% ± 8% | |
lung | 11 studies | 24% ± 8% | |
liver | 6 studies | 32% ± 14% | |
intestine | 5 studies | 25% ± 5% | |
kidney | 4 studies | 24% ± 8% | |
brain | 4 studies | 29% ± 8% | |
pancreas | 3 studies | 27% ± 2% | |
bone marrow | 3 studies | 21% ± 8% | |
uterus | 3 studies | 28% ± 9% | |
lymph node | 3 studies | 26% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 99% | 257.77 | 1436 / 1445 | 38% | 0.72 | 69 / 183 |
stomach | 92% | 217.33 | 331 / 359 | 20% | 0.42 | 57 / 286 |
lung | 100% | 609.93 | 578 / 578 | 10% | 0.32 | 120 / 1155 |
intestine | 100% | 405.58 | 966 / 966 | 9% | 0.22 | 49 / 527 |
pancreas | 91% | 166.43 | 297 / 328 | 16% | 0.29 | 28 / 178 |
bladder | 100% | 357.76 | 21 / 21 | 4% | 0.19 | 20 / 504 |
breast | 100% | 453.19 | 459 / 459 | 3% | 0.11 | 37 / 1118 |
uterus | 100% | 377.40 | 170 / 170 | 3% | 0.07 | 15 / 459 |
ovary | 100% | 350.57 | 180 / 180 | 3% | 0.04 | 13 / 430 |
kidney | 99% | 307.48 | 88 / 89 | 4% | 0.10 | 33 / 901 |
thymus | 100% | 327.16 | 653 / 653 | 1% | 0.02 | 8 / 605 |
skin | 99% | 394.12 | 1783 / 1809 | 2% | 0.02 | 8 / 472 |
adipose | 100% | 481.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 100% | 465.37 | 258 / 258 | 0% | 0 | 0 / 230 |
spleen | 100% | 1013.16 | 241 / 241 | 0% | 0 | 0 / 0 |
prostate | 99% | 255.53 | 243 / 245 | 1% | 0.03 | 3 / 502 |
brain | 98% | 211.92 | 2590 / 2642 | 2% | 0.03 | 12 / 705 |
blood vessel | 100% | 342.75 | 1329 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1819.89 | 907 / 929 | 0% | 0 | 0 / 0 |
liver | 92% | 182.75 | 207 / 226 | 0% | 0.00 | 1 / 406 |
heart | 84% | 139.04 | 719 / 861 | 0% | 0 | 0 / 0 |
muscle | 65% | 78.09 | 519 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.07 | 2 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0032940 | Biological process | secretion by cell |
GO_0030593 | Biological process | neutrophil chemotaxis |
GO_0048246 | Biological process | macrophage chemotaxis |
GO_0048247 | Biological process | lymphocyte chemotaxis |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
GO_0008009 | Molecular function | chemokine activity |
Gene name | CKLF |
Protein name | CKLF-CMTM1 readthrough (Chemokine like factor) Chemokine-like factor (cDNA FLJ76534, highly similar to Homo sapiens chemokine-like factor (CKLF), transcript variant 2, mRNA) Chemokine-like factor (C32) |
Synonyms | HSPC224 CKLF1 CKLF-CMTM1 hCG_28824 UNQ410/PRO772 |
Description | FUNCTION: May play an important role in inflammation and regeneration of skeletal muscle . Essential for embryonic development (By similarity). .; FUNCTION: [Isoform 1]: Has chemotactic response in monocytes, neutrophils and lymphocytes . Binds CCR4 . . |
Accessions | Q9UBR5 E9PLU7 ENST00000345436.8 [Q9UBR5-4] ENST00000362093.4 [Q9UBR5-3] ENST00000534692.1 ENST00000264001.9 [Q9UBR5-1] Q5BJH6 ENST00000417030.2 [Q9UBR5-5] ENST00000527845.1 ENST00000351137.8 [Q9UBR5-2] |